Ipafricept, CAS 1391727-24-4

Product Description: Ipafricept (OMP-54F28; FZD8-Fc) is the first class of recombinant fusion proteins, consisting of the extracellular portion of the human fried-8 receptor fused to the Fc fragment of human IgG1 binding to the Wnt ligand. Ipafricept shows solid tumor inhibition activity, with well tolerance[1].

Applications: Cancer-programmed cell death

Formula: N/A

References: [1]Jimeno A, et al. A First-in-Human Phase I Study of the Anticancer Stem Cell Agent Ipafricept (OMP-54F28), a Decoy Receptor for Wnt Ligands, in Patients with Advanced Solid Tumors. Clin Cancer Res. 2017 Dec 15;23(24):7490-7497.

CAS Number: 1391727-24-4

Molecular Weight: N/A

Compound Purity: 99.80

Research Area: Cancer

Solubility: 10 mM in DMSO

Target: Wnt

• Artikelnummer: MEXHY-P99667-10
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99667-10
• Verpackungseinheit: 10 mg
• Mengeneinheit: STK
• Konjugat: Unconjugated